The first forum on source innovation diagnosis and new drugs was held in Baoshan
On August 5th, the first forum on innovative diagnosis and new drugs at the source was held in Baoshan High-tech Zone. The forum brought together big coffee makers from academic circles, entrepreneurs and investors from business circles to discuss the pace of accelerating the research and development of original drugs in the new era and promote the vigorous development of biomedical industry.
Chen Jie, Vice Mayor of Shanghai and Secretary of Baoshan District Committee, Xie Xiaoliang, Academician of China Academy of Sciences, Director of Changping National Laboratory and Professor of Peking University, Jin Li, Academician of China Academy of Sciences and President of Fudan University, Chen Dong, Academician of China Academy of Sciences and President of Shanghai Institute of Immunotherapy Innovation, Zheng Yichuan, member of the Standing Committee of the District Committee and executive deputy head of the district attended the forum.
Xie Xiaoliang, academician of China Academy of Sciences, director of Changping National Laboratory and professor of Peking University, gave a report entitled "Two medical innovations caused by two rounds of technological revolution after 20 years of human genome". The gradual completion of the human genome is a great scientific and technological revolution. The complete genome not only opens up new ideas for human genetics, but also brings revolutionary changes to more ideas about diseases and medicine.
Jin Li, an academician of China Academy of Sciences and president of Fudan University, gave a report entitled "Innovation and Application of Phenomics", introducing molecular signal pathways, translation and transcription, and up to the latest epigenetic modification, which opened up many ideas on what to do and how to do for source innovation, and gave insightful views on the layout and exploration of innovative targets.
Chen Dong, academician of China Academy of Sciences and president of Shanghai Institute of Immunotherapy Innovation, published the report "Immunotherapy and Transformation", which started with the biological mechanism of diseases and actively carried out translational medicine research, and gained in-depth and unique insight into the target diseases, which was unprecedented and refreshing.
In innovation practice, the forum also invited Ma Qiufu, a professor at West Lake University, to give a report on "Innovation and Application of Acupuncture and Systemic Neurobiology". It is unique to integrate traditional empirical medicine with modern biomedical theory. This is also a historic breakthrough in acupuncture research and will have a revolutionary impact on future clinical practice.
Professor Xu Tian, vice president of West Lake University, founder of Medicine Farm and chief scientific consultant of Fosun Pharma, published the report "When artificial intelligence meets the transformation and application of biomedicine", which can be described as cold thinking under the increasingly hot artificial intelligence craze. Starting from biomedicine, this paper combed how artificial intelligence can be used for research, medicine, wisdom and ability, and put forward insightful insights and opinions.
Speech by Zheng Yichuan, member of the Standing Committee of District Party Committee and executive deputy head of district.
In the round-table session after the academic report, Xie Xiaoliang, Jin Li, Dong Chen and Ma Qiufu made wonderful speeches in the discussion on "The Pain Point of the Research on Source Innovation Transformation" presided by Professor Xu Tian.
The forum also held a launching ceremony for Shanghai Yaoyuan Bio, the global R&D center of drug ranch, a source innovation enterprise introduced by Baoshan. The leaders of Baoshan District, academia, industry and capital circles witnessed the good news that the first original new drug DF003, which was born in Baoshan with completely independent intellectual property rights in terms of targets and compounds, was approved by FDA for Phase I clinical trial.
The district science and technology commission introduced the industrial development and investment promotion policy of Baoshan District.
Biomedical industry is huge and complex, and the research and development of new drugs with original innovation is the most difficult and key hand in the industry. In the future, Baoshan High-tech Zone will further pool resources, promote the sustainable development of original drug research and development and scientific and technological innovation, and take up the main force of scientific and technological innovation for Baoshan and even Shanghai to a higher level.
Reporter: Sun Xiaochen and Gu Guorong
Editor: Song Ge
* Please indicate the official WeChat from Baoshan, Shanghai.
Declaration: All article resources on this website, unless otherwise specified or labeled, are collected from online resources. If the content on this website infringes on the legitimate rights and interests of the original author, you can contact this website to delete it.
